CAXTON CORP Diversified Active

Location: Princeton, NJ

CIK: 0001388551 · Show all filings

Period: Q2 2020 (← Previous) (Next →)

Filing Date: Aug 14, 2020

Total Value: $94.74M (100.0% shares, 0.0% debt)

Holdings (15)

— MOLECULAR TEMPLATES INC 30.7%
Value $29.07M Shares 2,107,991 Share Price $13.79 Est. Cost/Share $8.09 Unrealized @ Report Date —
— STRONGBRIDGE BIOPHARMA PLC 26.4%
Value $24.99M Shares 6,612,065 Share Price $3.78 Est. Cost/Share $2.92 Unrealized @ Report Date —
CRDF CARDIFF ONCOLOGY INC 8.4%
Value $7.992M Shares 1,595,164 Share Price $5.01 * Est. Cost/Share $2.05 Unrealized @ Report Date 0.0%
— SIERRA ONCOLOGY INC 8.2%
Value $7.792M Shares 643,959 Share Price $12.10 Est. Cost/Share $9.82 Unrealized @ Report Date —
— KALA PHARMACEUTICALS INC 6.9%
Value $6.519M Shares 620,289 Share Price $10.51 Est. Cost/Share $6.04 Unrealized @ Report Date —
— SCYNEXIS INC 6.3%
Value $5.967M Shares 7,946,111 Share Price $0.75 Est. Cost/Share $1.12 Unrealized @ Report Date —
— GARRISON CAP INC 4.2%
Value $3.935M Shares 1,164,061 Share Price $3.38 Est. Cost/Share $8.25 Unrealized @ Report Date —
GLD SPDR GOLD TR 2.8%
Value $2.665M Shares 15,923 Share Price $167.37 Est. Cost/Share $167.37 Unrealized @ Report Date —
— SATSUMA PHARMACEUTICALS INC 2.1%
Value $1.961M Shares 68,172 Share Price $28.77 Est. Cost/Share $15.01 Unrealized @ Report Date —
— MEI PHARMA INC 1.3%
Value $1.221M Shares 295,560 Share Price $4.13 Est. Cost/Share $3.83 Unrealized @ Report Date —
— EIGER BIOPHARMACEUTICALS INC 0.8%
Value $787K Shares 81,983 Share Price $9.60 Est. Cost/Share $10.26 Unrealized @ Report Date —
— CTI BIOPHARMA CORP 0.8%
Value $719K Shares 619,460 Share Price $1.16 Est. Cost/Share $1.19 Unrealized @ Report Date —
— IVERIC BIO INC 0.7%
Value $636K Shares 124,771 Share Price $5.10 Est. Cost/Share $5.10 Unrealized @ Report Date —
KURA KURA ONCOLOGY INC 0.4%
Value $333K Shares 20,406 Share Price $16.32 * Est. Cost/Share $17.68 Unrealized @ Report Date -18.4%
— ADDEX THERAPEUTICS LTD 0.2%
Value $152K Shares 17,418 Share Price $8.73 Est. Cost/Share $6.60 Unrealized @ Report Date —